Skip to main content
Veeva Systems Inc (VEEV)
Computer Software and Services Information Technology
Stock AI

Veeva Systems Inc. Reports Strong Fiscal 2026 Results Amidst Industry Transformation

Last updated: March 04, 2026
Taurigo

Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences sector, has announced its impressive financial results for the fourth quarter and fiscal year ended January 31, 2026. The company's performance highlights its commitment to innovation and customer success in a rapidly evolving industry landscape.

1. CEO's Perspective on Industry Opportunities

Peter Gassner, CEO of Veeva, emphasized the transformative changes occurring within the life sciences industry, presenting a substantial opportunity for growth. "The agentic transformation underway represents a substantial opportunity for Veeva and life sciences," he stated. Gassner noted that Veeva's core systems of record, which span critical industry functions and unique datasets, allow the company to deliver industry-specific AI that is deeply integrated into its applications. This strategic focus on Veeva AI, alongside robust performance in Commercial Cloud, Development Cloud, and Quality Cloud, is expected to create significant value for stakeholders.

2. Fiscal 2026 Fourth Quarter Highlights

Veeva's fourth quarter results showcased remarkable growth:

  • Revenues: Total revenues reached $836.0 million, reflecting a 16% increase compared to $720.9 million in the same period last year. Subscription revenues also rose by 16% to $707.7 million, up from $608.6 million.
  • Operating Income: The company reported an operating income of $245.9 million, a robust 30% increase from $188.4 million in the prior year. Non-GAAP operating income for the quarter was $366.5 million, marking a 19% rise year-over-year.
  • Net Income: Veeva's net income for the fourth quarter was $244.2 million, up 25% from $195.6 million year over year. Non-GAAP net income showed a similar trend, rising 20% to $346.1 million from $287.9 million.
  • Earnings Per Share: Fully diluted net income per share was $1.45, an increase from $1.18 the previous year, while non-GAAP fully diluted net income per share rose to $2.06 from $1.74.

3. Fiscal Year 2026 Financial Performance

For the fiscal year ending January 31, 2026, Veeva reported substantial gains:

  • Total Revenues: The company achieved total revenues of $3,195.3 million, a 16% increase from $2,746.6 million in the preceding year. Subscription revenues grew by 17% to $2,684.2 million.
  • Operating Income: Veeva's operating income for the fiscal year was $916.4 million, up 33% from $691.4 million last year, while non-GAAP operating income increased by 24% to $1,433.8 million.
  • Net Income: The fiscal year net income reached $908.9 million, a 27% increase from $714.1 million. Non-GAAP net income also rose 24%, totaling $1,352.5 million.
  • Earnings Per Share: The fully diluted net income per share was $5.44, up from $4.32, with non-GAAP fully diluted net income per share rising to $8.10 from $6.60.

4. Strategic Developments and Innovations

Veeva's growth can be attributed to several strategic initiatives:

Strengthening Industry Partnerships

The company finished the year with 1,552 customers, including 1,196 in Veeva R&D and Quality Solutions and 767 in Veeva Commercial Solutions. Veeva's achievement of a $3 billion revenue run rate in early 2025 underscores its consistent performance.

Advancements in AI Integration

Veeva is pioneering innovation with its Veeva AI, which utilizes specialized datasets and deep process integration to deliver high-value AI solutions. The recent rollout of Veeva AI Agents for CRM and commercial content has attracted numerous customers, with more projects expected throughout 2026.

Leadership in R&D and Quality

The company has made significant strides in its Development Cloud and Quality Cloud, securing several top 20 biopharma wins and enhancing its application offerings.

Focus on Commercial Success

With the Vault CRM, Veeva is spearheading the transition to agentic CRM within the life sciences sector. Over 125 customers have adopted Vault CRM, including several top biopharmas, with more expected to follow suit.

5. Looking Ahead: Financial Outlook

Veeva provided guidance for its fiscal first quarter ending April 30, 2026, predicting total revenues between $855 million and $858 million, with non-GAAP operating income projected between $378 million and $381 million. For the fiscal year ending January 31, 2027, the company expects total revenues between $3,585 million and $3,600 million, with non-GAAP operating income around $1,590 million.

6. Conclusion

Veeva Systems Inc. has demonstrated a solid financial performance for the fourth quarter and fiscal year 2026, driven by strategic innovation and a robust customer base. As the company continues to navigate the evolving landscape of the life sciences industry, its focus on AI integration and commercial success positions it well for future growth.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.